Navigation Links
Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications
Date:12/8/2009

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Mesenchymal Stem Cells, Advances & Applications

http://www.reportlinker.com/p0167257/Mesenchymal-Stem-Cells-Advances--Applications.html

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and potentially, neuronal cells.

MSCs are of intense therapeutic interest because they represent a population of cells with the potential treat a wide range of acute and degenerative diseases. MSCs are advantageous over other stem cells types for several reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found that human MSCs are immuno-privileged, and therefore, represent an advantageous cell type for allogenic transplantation, reducing the risks of rejection and complications of transplantation. Recently, there have also been significant advances in the use of autologous MSCs to regenerate human tissues, including cartilage and meniscus, tendons, and bone fractures.

This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. Additionally, this report provides guidance for companies that offer or wish to offer competitive stem cells products to this rapidly growing, well-funded research community.

I. Applications

A. Basic Research Applications

1. Directed Differentiation of Autologous MSCs towards Intra-Mesenchymal Lineages

2. Directed Differentiation of Autologous MSCs towards Extra-Mesenchymal Lineages

B. Supporting Hematopoietic Cells

C. Cell-Based Therapy Applications

1. Gene Transfer Applications

2. Allogenic Transplantation

3. Applications of MSCs for Osteochondral Repair

4. Applications of MSCs for Myocardiac Repair

5. Therapeutic Potential beyond Mesenchymal Lineages

D. Use of MSC in 3-D Scaffolds for Tissue Engineering Applications

II. Application Priorities

A. Overall

B. By Segment

1. Academic

2. Biotech

3. Pharma

III. Potential Labs/Customers

A. General MSC Research Labs

B. Osteogenic-Focused Research Labs

C. Myogenic and Myocardial-Focused Research Labs

D. Adipogenic-Focused Research Labs

E. Neuronal-Focused Research Labs

F. Immunology-Focused Research Labs

G. Commercial Labs

H. NIH Labs

IV. Companies Offering Human MSC Research Products, including Products Offered

A. Stem Cell Technologies

B. Thermo Scientific

C. Invitrogen

D. Celprogen

E. ScienCell Research Laboratories

F. Abcam

G. BD Biosciences

F. Millipore

V. Companies Offering Rodent MSC Research Products, including Products Offered

A. Cell Applications

B. Millipore

C. Celprogen

D. Cyagen Biosciences

E. ScienCell Research Laboratories

VI. Projected 5-Year Market Growth

A. Scientific Publication Trend Analysis

B. Grant Rate Trend Analysis

C. Patent Trend Analysis

VII. Mesenchymal Stem Cells as Tools for Drug Discovery

A. Companies Developing Toxicology Screening Platforms for Stem Cells

B. Advantages of Using Human MSCs for Drug Screening

C. Potential Drug Screening Advantages of Rodent MSCs

1. Acquisition, Handling, and Differentiation Advantages

2. Genetic Manipulation of MSCs

3. Potential for Genetically Engineered MSC Reporter Lines

VIII. Advantages of Serum Free Supplements for Use in MSC Research

IX. Research Product Opportunities and Suggestions

A. MSCs Derived from Alternative Sources than Bone Marrow

B. Novel RMSC Differentiation Kits

C. Mesenchymal Stem Cell Expansion Media

D. Mesenchymal Stem Cell Markers

E. Mesenchymal Growth Factors

F. Monoclonal Antibodies and Kits for Phenotyping RMSCs

G. Chips for MicroArray Analysis of Gene Expression in RMSCs

X. Conclusions

To order this report:

Pharmaceutical Industry: Mesenchymal Stem Cells, Advances & Applications

More Market Research Report

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reportlinker Adds Sterilization Technologies: The U.S. Market
2. Reportlinker Adds Renal Disease Treatments: Products and Therapies
3. Reportlinker Adds Kinase Inhibitors: Global Markets
4. Reportlinker Adds Point of Care Diagnostics
5. Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets
6. Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015
7. Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
8. Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment
9. Reportlinker Adds The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
10. Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report
11. Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... June 25, 2017 , ... CareSet Labs released the Root ... Orleans. This is a new, greatly improved version of the Doctor Referral teaming dataset ... by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as released by ...
(Date:6/24/2017)... York (PRWEB) , ... June 24, 2017 , ... ... the Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers ... evenings and weekends so that visits to the dentist fit into their patients’ ...
(Date:6/23/2017)... ... 23, 2017 , ... By scoring 100% for fiscal management and accountability, the ... online charity evaluator, Charity Navigator, validating ANRF's work as a top charity in America. ... Charity Navigator and earns ANRF a spot on their “ 10 Charities Worth Watching ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
(Date:6/23/2017)... ... 2017 , ... Georgia State University will host the First ... two-day conference is focused on advancing scientific knowledge about the aggressive triple negative ... racial breast cancer-related disparities. The conference theme is “Illuminating Actionable Biology.” , Conference ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... , June 9, 2017 AirXpanders, Inc. (ASX: ... on the design, manufacture, sale and distribution of the ... the progress of its commercial roll-out in ... in more than one hundred (100) medical institutions and ... AeroForm offers a needle-free alternative for women who choose ...
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ) today ... R. Goodwin , U.S. District Court Judge for the ... entered a case management order in MDL 2325, American ... (the "MDL") that includes a provision requiring plaintiffs in ... specific causation within one hundred twenty (120) days of ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: